Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient

NCT04412031 | Completed

• 1 other identifier: 20_185
• Study Type: observational
• Target: 802
• Locations: 1 country
• Sites: 1

Brief Summary

The project is a part of the "Protocol for a multicentre study of nosocomial SARS-CoV2 transmission: The NOSO-COR Project" registered in ClinicalTrials (NCT04290780). In the current pandemic context, medical resources have often been exceeded. Developing, using artificial intelligence techniques, an algorithm capable of detecting patients at risk of acute respiratory distress following Sars-Cov2 infection could help physicians to optimize the treatment of patients and health decision-makers to optimize resources. Thus, the goal of this project is to create a prediction model using artificial intelligence to predict an unfavorable evolution of Covid-19 at the hospital admission of patients

Conditions

to Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of Patients

Outcome Measures

Primary Outcomes (1)

• Need of mechanical ventilation, transfer to an intensive care unit or death within 21 days of admission.

  within 21 days

Interventions

non applicable OTHER

non applicable

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The project is a part of the "Protocol for a multicentre study of nosocomial SARS-CoV2 transmission: The NOSO-COR Project" It is an international multicentre prospective, observational, hospital-based study in adults. It will include volunteer patients, care givers and healthcare professionals in France and hospitals affiliated with the GABRIEL network. Demographic and clinical data will be collected using case-report forms designed especially for the purpose of the project. A nasopharyngeal swab will be collected and tested for SARS-CoV2 by RT-PCR. Characteristics of the study participants, the proportion of confirmed nosocomial SARS-CoV2 infections relative to all patients with syndromes suggestive of 2019-nCoV infection will be analyzed.

You may qualify if:

• Participant must be 18 years or older at the time of signing the informed consent
• Volunteer patients, care givers and healthcare professionals in France and hospitals affiliated with the GABRIEL network. Demographic and clinical data will be collected using case-report forms designed especially for the purpose of the project.
• A nasopharyngeal swab will be collected and tested for SARS-CoV2 by RT-PCR.
• Admission to hospital

You may not qualify if:

• Age lower than 18 years old
• Patients protected by the law

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Hôpital E Herriot - Hospices Civils de LYON

Lyon, 69437, France

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 29, 2020
• First Posted: June 2, 2020
• Study Start: November 11, 2019
• Primary Completion: May 14, 2020
• Study Completion: May 15, 2020
• Last Updated: June 2, 2020

Record last verified: 2020-05

Locations

FR (1)